Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Glycopyrronium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 known ✓ | P20309 | 15/20 | 1.00 |
| ▸ | CHRM2 known ✓ | P08172 | 8/20 | 1.00 |
| ▸ | CHRM4 known ✓ | P08173 | 1/20 | 1.00 |
| ▸ | CHRM5 known ✓ | P08912 | 1/20 | 1.00 |
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 2/20 | 1.00 |
| ▸ | HRH1 | P35367 | 1/20 | 1.00 |
| ▸ | HTR2B | P41595 | 1/20 | 1.00 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycopyrronium SCHEMBL1900235 | 1.00 | CHRM3 (1.00) | CHRM3CHRM2KCNH2CHRM4CHRM5 | |
| Glycopyrronium SCHEMBL2012259 | 1.00 | CHRM3 (1.00) | CHRM3CHRM2KCNH2CHRM4CHRM5 | |
| Glycopyrronium SCHEMBL417981 | 1.00 | CHRM3 (1.00) | CHRM3CHRM2KCNH2CHRM4CHRM5 | |
| Glycopyrronium SCHEMBL417980 | 1.00 | CHRM3 (1.00) | CHRM3CHRM2KCNH2CHRM4CHRM5 | |
| Glycopyrronium SCHEMBL132614 | 1.00 | CHRM3 (1.00) | CHRM3CHRM2KCNH2CHRM4CHRM5 | |
| Glycopyrronium SCHEMBL2335685 | 1.00 | CHRM3 (1.00) | CHRM3CHRM2KCNH2CHRM4CHRM5 | |
| Glycopyrronium SCHEMBL131054 | 1.00 | CHRM3 (1.00) | CHRM3CHRM2KCNH2CHRM4CHRM5 | |
| Glycopyrronium SCHEMBL4106576 | 1.00 | CHRM3 (1.00) | CHRM3CHRM2KCNH2CHRM4CHRM5 | |
| Hexopyrronium SCHEMBL5391795 | 0.99 | CHRM3 (0.98) | CHRM3CHRM2KCNH2CHRM4CHRM5 | |
| Hexopyrronium SCHEMBL915388 | 0.99 | CHRM3 (0.98) | CHRM3CHRM2KCNH2CHRM4CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 16685 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122094727-A | Aerosol delivery device, component thereof and method of manufacturing the same | — | 2026-05-26 | — | — | CN | claimed |
| CN-224242693-U | Novel stigmine injection split charging structure of glycopyrronium bromide | 广州曼翔医药有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-117064869-B | Capsule type inhalation powder spray and preparation method thereof | 山东京卫制药有限公司 | 2026-05-12 | — | — | CN | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| EP-4736841-A1 | A MUCOADHESIVE LAYER FOR BUCCAL ADMINISTRATION OF AN ACTIVE PHARMACEUTICAL INGREDIENT | IQ medical GmbH (DE) | 2026-05-06 | — | — | EP | claimed |
| US-12616803-B2 | Apparatus for dispensing inhalant medicament | METOPI PHARMACEUTICALS, INC. (US) | 2026-05-05 | — | — | US | claimed |
| US-12616654-B2 | Stainless steel can for pressurised metered dose inhalers | CHIESI FARMACEUTICI S.P.A. (IT) | 2026-05-05 | — | — | US | claimed |
| US-20260102381-A1 | Muscarinic Agent Combinations | Syremis Therapeutics, Ltd. (IL) | 2026-04-16 | — | — | US | claimed |
| EP-4434588-B1 | AEROSOL DELIVERY DEVICE | PARI PHARMA GMBH (DE) | 2026-04-08 | — | — | EP | claimed |
| US-20260076958-A1 | LIQUID FORMULATIONS OF INDACATEROL | AERORX THERAPEUTICS INC (US) | 2026-03-19 | — | — | US | claimed |
| US-5525347-A | Composition and methods for treating performance anxiety | MEDICAL UNIVERSITY OF SOUTH CAROLINA (US) | 1996-06-11 | — | — | US | claimed |
| CN-1123180-A | \"Weichangning\"-medicine for curing gastrosis | LUO YAJUN (CN) | 1996-05-29 | — | — | CN | claimed |
| EP-0711292-A1 | AZA SPIRO COMPOUNDS ACTING ON THE CHOLINERGIC SYSTEM WITH MUSCARINIC AGONIST ACTIVITY | KOSMIN, Gerald, Emmanuel (GB) | 1996-05-15 | — | — | EP | claimed |
| WO-1995009006-A1 | MONOGLYCERIDE/LACTATE ESTER PERMEATION ENHANCER | ALZA CORPORATION (US) | 1995-04-06 | — | — | WO | claimed |
| WO-1995003303-A2 | AZA SPIRO COMPOUNDS ACTING ON THE CHOLINERGIC SYSTEM WITH MUSCARINIC AGONIST ACTIVITY | STATE OF ISRAEL, REPRESENTED BY THE PRIME MINISTER'S OFFICE, ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH (IL) | 1995-02-02 | — | — | WO | claimed |
| EP-0452101-A2 | Spiro bridged and unbridged heterocyclic compounds | ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH (IL) | 1991-10-16 | — | — | EP | claimed |
| US-5053412-A | Central nervous system disorders | ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH (IL) | 1991-10-01 | — | — | US | claimed |
| US-5008111-A | Pretreating skin with anticholinergic quaternary ammonium salt to suppress perspiration | SCHERING CORPORATION (US) | 1991-04-16 | — | — | US | claimed |
| US-4824676-A | ANTICHOLINERGIC AGENT TO SUPPRESS PERSPIRATION | SCHERING CORPORATION (US) | 1989-04-25 | — | — | US | claimed |
| EP-0140434-A2 | Pharmaceutical composition with systemic anticholineesterasic, agonistic-cholinergic and antimuscarinic activity | PRODOTTI FORMENTI S.r.l. (IT) | 1985-05-08 | — | — | EP | claimed |